Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Imprimis Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

Value Graph: IMPRIMIS PHARMA -- IMMY

26 Aug 2016 Ford Investor Services, Inc. 1 $12.00

IMPRIMIS PHARMACEUTICALS INC (IMMY=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

20 Aug 2016 Pechala's Reports 2 $25.00

ValuEngine Rating and Forecast Report for IMMY

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

14 Aug 2016 ValuEngine, Inc. 11 $25.00

Wright Investors Service Comprehensive Report for Imprimis Pharmaceuticals Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

10 Aug 2016 Wright Reports 61 $75.00

Thomson Reuters Stock Report - Imprimis Pharmaceuticals Inc (IMMY-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

05 Aug 2016 Thomson Reuters Stock Report 12 $25.00

Imprimis Pharmaceuticals, Inc. (IMMY) - Financial and Strategic SWOT Analysis Review

Imprimis Pharmaceuticals, Inc. (IMMY) - Financial and Strategic SWOT Analysis Review Summary Imprimis Pharmaceuticals, Inc. (...

05 Aug 2016 GlobalData 76 $300.00

Imprimis Pharmaceuticals, Inc. (IMMY) - Financial and Strategic SWOT Analysis Review

Imprimis Pharmaceuticals, Inc. (IMMY) - Financial and Strategic SWOT Analysis Review Summary Imprimis Pharmaceuticals, Inc. (...

03 Jun 2016 GlobalData 76 $300.00

Thomson Reuters Stock Report - Imprimis Pharmaceuticals Inc (IMMY-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 12 $25.00

IMMY.OQ - Event Transcript of Imprimis Pharmaceuticals Inc conference call, Mar. 23, 2016 / 4:30PM ET

Edited Event Transcript of IMMY.OQ conference call, Mar. 23, 2016 / 4:30PM ET Boston, Apr 12, 2016 (Thomson StreetEvent...

23 Mar 2016 Thomson Reuters StreetEvents 9 $75.00